ACTIVE

NEFROLOGIE IEPER

Financial year 2024 · Closed on 31/12/2024

Gross margin3,1 k €-18,4 %over 1 year
Equity19,4 k €0,0 %over 1 year

Identity

Source · BCE/KBO

NEFROLOGIE IEPER is a Private limited company incorporated in 2019. Its main activity is: Specialist medical practice activities. Its registered office is in Ieper.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0724.846.158
Incorporation
12/04/2019
Legal form
Private limited company
Registered office
Briekestraat 12
8900 Ieper · FlandreSee on map
Contributed capital
19 350,00 €
Latest accounts
31/12/2024
Signals
ProfitablePositive EBITDA

Financials

Source · NBB, 6 filings

Trend over 4 financial years

2024202320222021
Income statement
Gross margin3,1 k €3,8 k €2 k €1,4 k €
EBITDA2 k €2,7 k €990 €445,6 €
Operating result1 k €1,8 k €500,8 €445,6 €
Balance sheet
Equity19,4 k €19,4 k €19,4 k €19,4 k €
Total assets2,8 M €2,6 M €2,6 M €2,5 M €
Cash63 k €6,3 k €55,7 k €48,5 k €
Debts2,8 M €2,6 M €2,6 M €2,5 M €

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

7 active · 13 ended

Active mandates

Dr. Kelly De Schuyter

Director · since 01 mai 2025 · 1000.973.385

Represented by Kelly De Schuyter

Active
DR.PAULIEN VAN ACKER, NEFROLOGIE

Director · since 01 mai 2024 · 0780.524.158

Represented by Paulien Van Acker

Active
Ann Van Loo

Managing director

Active
Dr. Kristel De Keyzer, nefrologe

Managing director · 0507.754.022

Represented by Kristel De Keyzer

Active
Dr. Steven Vandewaeter

Director · 0681.891.093

Represented by Steven Vandewaeter

Active
DR. TERRYN WIM

Director · 0878.231.565

Represented by Wim Terryn

Active
DR. VAN BELLEGHEM HILDE

Director · 0810.821.020

Represented by Hilde Vanbelleghem

Active

Ended mandates

DR.PAULIEN VAN ACKER, NEFROLOGIE

Director · since 01 mai 2024 · 0780.524.158

Represented by Paulien VAN ACKER

Ended
Ann Van Loo

Managing director · since 03 avril 2019

Ended
Dr. Kristel De Keyzer, nefrologe

Managing director · since 03 avril 2019 · 0507.754.022

Represented by Kristel De Keyzer

Ended
Dr. Steven Vandewaeter

Director · since 03 avril 2019 · 0681.891.093

Represented by Steven Vandewaeter

Ended

Other companies at this address

Briekestraat 12 8900 Ieper
CompanyCBE no.
0725.699.560
0717.581.155
0655.874.507
1032.655.070
1041.636.577
1008.683.204
0715.673.918
0781.378.847
1001.694.650
0462.915.078
KLOPPEND HART● Active
0508.932.868
MKA WESTHOEK● Active
0713.698.482
0785.658.428
0262.926.319
1000.198.969

Full financial information

Source · NBB
202420232022202120202019
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202003/04/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months9 months
Filing date23/07/202518/07/202417/07/202313/07/202207/07/202117/07/2020
General meeting30/06/202524/06/202426/06/202330/06/202230/06/202129/06/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 6 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202430/06/202523/07/2025DutchPDF
Abridged model31/12/202324/06/202418/07/2024DutchPDF
Abridged model31/12/202226/06/202317/07/2023DutchPDF
Abridged model31/12/202130/06/202213/07/2022DutchPDF
Abridged model31/12/202030/06/202107/07/2021DutchPDF
Abridged model31/12/201929/06/202017/07/2020DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

7 active · 13 ended

Active mandates

Dr. Kelly De Schuyter

Director · since 01 mai 2025 · 1000.973.385

Represented by Kelly De Schuyter

Active
DR.PAULIEN VAN ACKER, NEFROLOGIE

Director · since 01 mai 2024 · 0780.524.158

Represented by Paulien Van Acker

Active
Ann Van Loo

Managing director

Active
Dr. Kristel De Keyzer, nefrologe

Managing director · 0507.754.022

Represented by Kristel De Keyzer

Active
Dr. Steven Vandewaeter

Director · 0681.891.093

Represented by Steven Vandewaeter

Active
DR. TERRYN WIM

Director · 0878.231.565

Represented by Wim Terryn

Active
DR. VAN BELLEGHEM HILDE

Director · 0810.821.020

Represented by Hilde Vanbelleghem

Active

Ended mandates

DR.PAULIEN VAN ACKER, NEFROLOGIE

Director · since 01 mai 2024 · 0780.524.158

Represented by Paulien VAN ACKER

Ended
Ann Van Loo

Managing director · since 03 avril 2019

Ended
Dr. Kristel De Keyzer, nefrologe

Managing director · since 03 avril 2019 · 0507.754.022

Represented by Kristel De Keyzer

Ended
Dr. Steven Vandewaeter

Director · since 03 avril 2019 · 0681.891.093

Represented by Steven Vandewaeter

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates23/05/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates27/05/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares28/12/2023
    DOEL - KAPITAAL - AANDELEN
    PDF
  • Mandates18/01/2021
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other16/04/2019
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024
  2. 2023
    Annual accounts 2023
  3. 2022
    Annual accounts 2022
  4. 2021
    Annual accounts 2021
  5. 12/04/2019
    IncorporationPrivate limited company